Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronically progressive fibrotic pulmonary disease characterized by an uncertain etiology, a poor prognosis, and a paucity of efficacious treatment options. Dexmedetomidine (Dex), an anesthetic-sparing alpha-2 adrenoceptor (α2AR) agonist, plays a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Xiaofan, Lin, Yingying, Huang, Shaojie, Pu, Lvya, Zeng, Qihao, Wang, Zhongxing, Huang, Wenqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464018/
https://www.ncbi.nlm.nih.gov/pubmed/37644529
http://dx.doi.org/10.1186/s12931-023-02513-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464018/
https://www.ncbi.nlm.nih.gov/pubmed/37644529
http://dx.doi.org/10.1186/s12931-023-02513-3

Ejemplares similares